• Earl V. Miller, Vaccinogen Director of Finance & Corporate Controller

Director of Finance & Corporate Controller

Mr. Miller has over 20 years of multi-disciplinary experience in the full cycle of financial reporting and compliance control. His experience includes both private and public companies in a variety of industries, including biotech. In his role as Controller he has a proven track record of instituting financial governance controls and reports, process improvements, implementing Sarbanes-Oxley, SEC Reporting, MD&A analysis, operational cost savings, reorganizations, and treasury and cash management.

Mr. Miller has held Controller and Business Consultant positions at Stanley Black & Decker, SafeNet, BioVeris (an electrochemiluminescence diagnostic technology company acquired by Roche), and Celsion an oncology drug development company. Mr. Miller has also held positions as an Accounting Manager at both Axcelis Technologies and Random House.

Mr. Miller earned his B.S. in Accounting at Towson University, and his MBA at Mt. St. Mary’s University.